20/21 February 2024
Munich, Germany
Again, the "Frequently asked questions about parallel distribution" were revised and published on the EMA website. The information provided by the EMA on parallel distribution of centrally authorised medicinal products is set out in the Q&A in six paragraphs:
In the latest version, the following question has been added to the first section "General":
In the fifth paragraph "Safety updates/bulk changes/annual update", questions 4 and 5 and their answers have been updated:
The four other sections remain unchanged.
The updates and the complete list of answers to the "Frequently asked questions about parallel distribution" can be found on the EMA website.